Bibliography
- MCCONNELL JD, ROEHRBORN CG, BAUTISTA OM iet al.: i The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. iN Engl. J. Med. i (2003) 349:2387–2398.
- GORMLEY GI, STONER E, BRUSKEWITZ RC iet al.: i The effect of finasteride in men with benign prostatic hyperplasia. iN Engl. J. Med. i (1992) 327:1185–1191.
- BOYLE MJ, FOWLER FJ Jr, O'LEARY MP iet al: i Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials. iUrology i (1996) 48:398–405.
- DOGGRELL SA: Present and future pharmacotherapy for benign prostatic hyperplasia. iDrugs of the Future i (2002) 27:973–986.
- LEPOR H, WILLIFORD WO, BARRY MJ iet al.: i The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. iN Engl. J. Med. i (1996) 335:533–539.
- LEPOR H, WILLIFORD WO, BARRY iet al.: i The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.," iUrol. i (1998) 160:1358–1367.
- KIRKBY RS, ROEHRBORN C, BOYLE P iet al.: i Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European and Combination Therapy (PREDICT) trial. iUrology (2003) i 61:119–126.
- KENNY BA, MILLER AM, WILLIAMSON IJ iet al.: i Evaluation of the pharmacological selectivity of a-adrenoceptors at prostatic a-adrenoceptors: Binding functional and in vivo studies. iBr. J. Pharmacol i (1996) 118:871-878. Affiliation Sheila A Doggrell Doggrell Biomedical Communications, 47 Caronia Crescent, Lynfield, Auckland, New Zealand E-mail: [email protected]